General Information of the Compound
Compound ID |
CP0543385
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1,1-dioxo-2-[5-(4-pyridin-2-ylpiperazin-1-yl)pentyl]-1,2-benzothiazol-3-one
Show/Hide
|
||||||||||||||||||
Formula |
C21H26N4O3S
|
||||||||||||||||||
Molecular Weight |
414.531
|
||||||||||||||||||
Canonical SMILES |
O=C1N(CCCCCN2CCN(CC2)c2ccccn2)S(=O)(=O)c2ccccc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C21H26N4O3S/c26-21-18-8-2-3-9-19(18)29(27,28)25(21)13-7-1-6-12-23-14-16-24(17-15-23)20-10-4-5-11-22-20/h2-5,8-11H,1,6-7,12-17H2
Show/Hide
|
||||||||||||||||||
InChIKey |
NJMHKVAICPWFEV-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7
Protein ID: PT01005, D(2) dopamine receptor